NDC properties for NDC 9 0597-0560
NDC item 00597056012
| NDC 9 | 0597-0560 |
|---|---|
| NDC 10 | 0597-0560-12 |
| NDC Item | 00597056012 |
| packaging | 0.4 mL in 1 SYRINGE |
| packaging | 1 in 1 TRAY |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |
NDC item 00597056520
| NDC 9 | 0597-0565 |
|---|---|
| NDC 10 | 0597-0565-20 |
| NDC Item | 00597056520 |
| packaging | 2 KIT in 1 CARTON (0597-0565-20) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (0597-0560-12) / .4 mL in 1 SYRINGE * 1 mL in 1 PACKET |
| BLA | BLA761058 |
| Labeler | Boehringer Ingelheim Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-30 |
| Marketing status | ACTIVE |
NDC item 82009014622
| NDC 9 | 82009-146 |
|---|---|
| NDC 10 | 82009-146-22 |
| NDC Item | 82009014622 |
| packaging | 2 KIT in 1 CARTON (82009-146-22) / 1 KIT in 1 KIT * 1 SYRINGE in 1 TRAY (82009-147-11) / .4 mL in 1 SYRINGE * 2 PACKET in 1 TRAY / 1 mL in 1 PACKET |
| BLA | BLA761058 |
| Labeler | QUALLENT PHARMACEUTICALS HEALTH LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-30 |
| Marketing status | ACTIVE |
NDC item 82009014711
| NDC 9 | 82009-147 |
|---|---|
| NDC 10 | 82009-147-11 |
| NDC Item | 82009014711 |
| packaging | 0.4 mL in 1 SYRINGE |
| packaging | 1 in 1 TRAY |
| Labeler | QUALLENT PHARMACEUTICALS HEALTH LLC |
| Label type | HUMAN PRESCRIPTION DRUG LABEL |